Cibinqo 100 mg (Abrocitinib TABLET) 100 MG

CIBINQO 100 MG tablets contain abrocitinib, a medication used to manage moderate to severe eczema. This oral treatment helps reduce inflammation and relieve symptoms.

Strength

100 MG

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CIBINQO 100 MG tablets are primarily used for the treatment of moderate to severe atopic dermatitis, commonly known as eczema. This medication works by targeting inflammation in the skin, helping to alleviate symptoms such as itching, redness, and rash. People often ask, 'What is CIBINQO used for?' and the answer is that it is designed to provide relief from the discomfort associated with eczema.

Side Effects

When taken as directed, CIBINQO 100 MG tablets may help reduce the frequency and severity of eczema flare-ups. Common effects include improved skin appearance and reduced itching. However, individual responses can vary, and it's important to monitor for any adverse reactions.

Precautions & Warnings

CIBINQO 100 MG tablets should be handled with care. It is essential to follow the advice of a healthcare provider regarding its use. People with certain medical conditions or those taking other medications should discuss potential risks with their healthcare provider before starting this treatment.

Avoid Interactions

CIBINQO 100 MG tablets may interact with other medications, including those that affect the immune system or metabolism. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol and certain foods may influence the effectiveness of this medication.

Frequently Asked Questions

CIBINQO 100 MG tablets are used to treat moderate to severe atopic dermatitis, commonly known as eczema.

CIBINQO works by targeting inflammation in the skin, helping to reduce symptoms such as itching, redness, and rash.

Common effects include improved skin appearance and reduced itching, though individual responses can vary.

It is important to discuss with a healthcare provider before taking CIBINQO with other medications to avoid potential interactions.

Follow the advice of a healthcare provider and inform them of any medical conditions or other medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.